Advancing Insights into Progression of Acute Kidney Injury with Sepsis: Early Detection and Management

Acute kidney injury (AKI) associated with sepsis is a major contributor to morbidity and mortality in critically ill patients. The progression of sepsis-induced AKI (S-AKI) is complex and involves a dysregulated immune response, including systemic inflammation, endothelial dysfunction, and microvascular injury. These mechanisms compromise renal function, leading to significant challenges in management. Early detection and timely intervention are crucial to improving outcomes, yet effective treatment strategies remain elusive. Advances in understanding the pathophysiology of S-AKI have provided critical insights into the underlying mechanisms of kidney damage during sepsis. These insights have led to the identification of potential biomarkers that can aid in early diagnosis, predict disease progression, and guide therapeutic decisions. Current management of S-AKI includes fluid resuscitation, broad-spectrum antibiotics, and renal replacement therapy (RRT), aimed at stabilizing the patient and supporting renal function. Emerging therapies, such as novel pharmacological agents and approaches to modulate the immune response, are under investigation, offering promise for improving clinical outcomes. However, more research is needed to validate these treatments and ensure their safety and efficacy. The advancing insights into the pathophysiology of S-AKI, coupled with the development of innovative diagnostic tools and therapeutic strategies is critical for improving the management of sepsis-induced kidney injury. Future research should focus on bridging the gap between basic science, clinical practice, and large-scale clinical trials to optimize care and outcomes for patients suffering from S-AKI. Keywords: Sepsis, Acute kidney injury, Immune response, Systemic inflammation, Endothelial dysfunction, Microvascular injury.